V112 CDC hemodialysis recommendations, adopted by reference
Written V0112 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§494.30(a) - Standard: Procedures for infection control. The facility must demonstrate that it follows standard infection control precautions by implementing— (1)(i) The recommendations (with the exception of screening for Hepatitis C), found in “Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients,” developed by the Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report, volume 50, number RR05, April 27, 2001, pages 18 to 28. The Director of the Federal Register approves this incorporation by reference in accordance with 5 U.S.C. 552(a) and 1 CFR Part 51. This publication is available for inspection at the CMS Information Resource Center, 7500 Security Boulevard, Central Building, Baltimore, MD or at the National Archives and Records Administration (NARA). Copies may be obtained at the CMS Information Resource Center. For information on the availability of this material at NARA, call 202–741–6030, or go to:
http://www.archives.gov/federal_register/code_of_regulations/ibr_locations.html. The recommendation found under section header “HBV-Infected Patients”, found on pages 27 and 28 of RR05 (“Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients”), concerning isolation rooms, must be complied with by February 9, 2009.
Appendix H quotes this text a little differently from the regulation as published today. The eCFR has the current wording.
CMS's interpretive guidance
Interpretive Guidelines § 494.30(a)
The CDC “Recommendations for Preventing Transmission of Infections among Chronic Hemodialysis Patients” (MMWR, Vol. 50/No. RR-05), pages 18 to 28, including the “Recommended Infection Control Practices for Hemodialysis Units at a Glance,” found at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005a1.htm is incorporated by reference into the regulation and, thus, facilities must demonstrate that they follow standard infection control precautions by implementing its recommendations. For the purposes of these Conditions for Coverage, the portions of the CDC infection control recommendations incorporated by reference are mandatory and must be adhered to and demonstrated within the dialysis facility. When serving as Regulation text, the words of the CDC document are excerpted exactly as written. The entire CDC document includes background information and rationale for the CDC-recommended practices and can be used as an informational resource.
Note: When words are inserted or altered in a direct quotation, square brackets—[ ]— are placed around the change. The brackets enclose words intended to explain the quote or to help integrate the quote into the guidance.
According to the CDC, “preventing transmission among chronic hemodialysis patients of blood-borne viruses and pathogenic bacteria from both recognized and unrecognized sources of infection requires implementation of a comprehensive infection control program. The components of such a program include infection control practices specifically designed for the hemodialysis setting, including routine serologic testing and immunization, surveillance, training and education.”
CDC’s components of a comprehensive infection control program to prevent transmission of infections among chronic hemodialysis patients include:
- Infection control practices for hemodialysis units.
- Infection control precautions specifically designed to prevent transmission of bloodborne viruses and pathogenic bacteria among patients.
- Routine serologic testing for Hepatitis B virus infections.
- Vaccination of susceptible patients against Hepatitis B.
- Isolation of patients who test positive for Hepatitis B surface antigen.
- Surveillance for infections and other adverse events.
- Infection control training and education.
The infection control practices recommended by CDC for hemodialysis units will reduce opportunities for patient-to-patient transmission of infectious agents, directly or indirectly through contaminated devices, equipment, and supplies, environmental surfaces, or hands of personnel. These practices should be carried out routinely for all patients in the chronic hemodialysis setting because of the increased potential for blood contamination during hemodialysis and because many patients are colonized or infected with pathogenic bacteria. These infection control practices include additional measures to prevent Hepatitis B Virus (HBV) transmission because of the high titer of HBV in each milliliter of infected blood and its ability to survive on environmental surfaces.
According to the CDC, for patients at increased risk for transmission of pathogenic bacteria, including antimicrobial-resistant strains, additional precautions might also be necessary. Patients with either an infected skin wound with drainage uncontrolled by dressings, or uncontrolled fecal incontinence or diarrhea, should be dialyzed at a station with as few adjacent stations as possible. Staff members treating the patient should wear a separate gown for patient care, and supplies and equipment (such as blood pressure cuffs) should not be shared between patients with uncontrolled draining wounds.
Surveillance for infections and other adverse events is necessary to monitor the effectiveness of infection control practices, as well as to train and educate both staff members and patients on appropriate infection control behaviors and techniques.
https://middlemolecule.com/rulebook/tags/v112/